Dahili Tıp Bilimleri Bölümü
Permanent URI for this communityhttps://hdl.handle.net/20.500.12514/3078
Browse
Browsing Dahili Tıp Bilimleri Bölümü by Scopus Q "Q2"
Now showing 1 - 5 of 5
- Results Per Page
- Sort Options
Article Citation - WoS: 3Aging and cardiac implantable electronic device complications: is the procedure safe in older patients?(ELSEVIER, 2023) Güzel, Tuncay; Aktan, Adem; Kılıç, Raif; Günlü, Serhat; Arslan, Bayram; Arpa, Abdulkadir; Güzel, Hamdullah; Tatlı, İsmail; Aydın, Saadet; Suzan, Veysel; Demir, MuhammedBackground In this study, we investigated whether there is a higher incidence of cardiac implantable electronic devices (CIED) procedures related complications in older (≥75 years) than in younger (<75 years) patients. Methods This retrospective cohort study enrolled patients who had undergone CIED procedures (de novo implantation, system upgrade, generator substitution, pocket revision or lead replacement) at two heart centers in Turkey between January 2011 and May 2023. The primary composite endpoint included clinically signifcant hematoma (CSH), pericardial efusion or tamponade, pneumothorax, and infection related to the device system. Secondary outcomes included each component of the composite end point. Results The overall sample included 1923 patients (1419<75 years and 504 aged≥75 years). There was no diference between the groups in terms of cumulative events defned as primary outcome (3.5% vs. 4.4%, p=0.393). Infection related to device system was signifcantly higher in the≥75 age group (1.8% vs. 3.4%, p=0.034). There was no signifcant diference between the groups in terms of clinically signifcant hematoma and pneumothorax (0.7% vs. 0.4%, p=0.451, 1.4% vs. 1.0%, p=0.477, respectively). In multivariate model analysis, no association was found between age≥75 years and infection related to the device system. Conclusion Infection rates were relatively higher in the patient group aged≥75 years. This patient group should be evaluated more carefully in terms of infection development before and after the procedure.Article Citation - WoS: 3Citation - Scopus: 3Aging and cardiac implantable electronic device complications: is the procedure safe in older patients?(Springer, 2023) Güzel, Tuncay; Aktan, Adem; Kılıç, Raif; Günlü, Serhat; Arslan, Bayram; Arpa, Abdulkadir; Güzel, Hamdullah; Tatlı, İsmail; Aydın, Saadet; Suzan, Veysel; Demir, MuhammedBackground: In this study, we investigated whether there is a higher incidence of cardiac implantable electronic devices (CIED) procedures related complications in older (≥ 75 years) than in younger (< 75 years) patients. Methods: This retrospective cohort study enrolled patients who had undergone CIED procedures (de novo implantation, system upgrade, generator substitution, pocket revision or lead replacement) at two heart centers in Turkey between January 2011 and May 2023. The primary composite endpoint included clinically significant hematoma (CSH), pericardial effusion or tamponade, pneumothorax, and infection related to the device system. Secondary outcomes included each component of the composite end point. Results: The overall sample included 1923 patients (1419 < 75 years and 504 aged ≥ 75 years). There was no difference between the groups in terms of cumulative events defined as primary outcome (3.5% vs. 4.4%, p = 0.393). Infection related to device system was significantly higher in the ≥ 75 age group (1.8% vs. 3.4%, p = 0.034). There was no significant difference between the groups in terms of clinically significant hematoma and pneumothorax (0.7% vs. 0.4%, p = 0.451, 1.4% vs. 1.0%, p = 0.477, respectively). In multivariate model analysis, no association was found between age ≥ 75 years and infection related to the device system. Conclusion: Infection rates were relatively higher in the patient group aged ≥ 75 years. This patient group should be evaluated more carefully in terms of infection development before and after the procedure.Article Citation - WoS: 7Citation - Scopus: 10Metabolic Syndrome in School Children in Mardin, South-Eastern of Turkey(AVES Ibrahim Kara, 2014) Battaloğlu İnanç, BetülAmaç: Okul çocukları popülasyonunda, metabolik sendrom (MES) prevelansının tespit edilmesi amaçlandı.Gereç ve Yöntem: Türkiye'nin güneydoğusundaki, Mardin şehir merkezinde, üç ilköğretim okulundaki, 7-15 yaşları arası, üç bin dört yüz altmış çocuk, Nisan-Mayıs 2011'de çalışmaya dahil edildi. Yaş, cins, boy, ağırlık, bel çevresi, kalça çevresi, bel/kalça oranı, sistolik ve diyas tolik kan basınçları ölçüldü ve kan testleri kaydedildi. MES tanısı için Uluslararası Diyabet Federasyonu (IDF) kriterleri kullanıldı.Bulgular: Çocukların %9,42'si fazla kilolu ve %8'i obezdi. Obezite kızlarda %9,1, erkekler de %6,9'du. Obezite prevelansı, kızlar arasında erkeklerden daha yüksek ve anlamlıydı (p<0.001). Vücut kitle indeksi (VKI) ve bel ve kalça çevresi, bel/kalça oranı, sistolik ve diyasto lik kan basıncı, trigliserid arasında pozitif korelasyon bulundu (p=0.0001). Total kolesterol, trigliserid, VKI, sistolik ve diyastolik kan basıncı obez MES'lu grupta, obez olmayanlardan anlamlı farklı idi (p<0.05). Kızların bel/kalça oranı referans değerleri, erkeklerinkinden anlamlı olarak daha yüksekti (p>0.05). MES prevelansı %6,3'tü. MES, kızlarda ve obezlerde daha yüksekti. Obez çocuklarda MES oranı %30,3'tü.Sonuç: Çocukluk döneminde obezite, hipertansiyon ve MES sıklığı her geçen gün artmakta dır. Santral obezite ve yüksek vücut kitle indeksine sahip olan çocuklar, MES için daha dikkat li değerlendirilmelidir. Ve toplumun yaşam kalitesi, yaşam tarzı değişiklikleri ile risklerin azaltılması yoluna gidilerek, gerekli tedavi ve takiplerle sağlanmalıdır.Article Citation - WoS: 2Citation - Scopus: 2Evaluation of patients diagnosed with congenital hypothyroidism by newborn screening between 2011-2019 in Diyarbakir, Turkey(LWW, 2023) Toktaş, İzzettin; Erdem, Özgür; Sarıbaş, Seyfettin; Özbek, Mehmet NuriThis study aimed to determine the incidence of congenital hypothyroidism in Turkey’s Diyarbakir Province and assess the development and growth conditions of people with congenital hypothyroidism. Patients born between 2011-2019 and diagnosed with congenital hypothyroidism within the scope of the newborn screening program were included. The medical records of these patients were retrospectively reviewed. The length and weight for age, weight for length, and body mass index standard deviation scores were calculated. We investigated the treatment status of the patients, whether their relatives had a similar disorder, and the presence of consanguinity between parents. Blood samples were collected from 380,592 newborns. As a result of further tests, 498 newborns were diagnosed with congenital hypothyroidism (incidence: 1/764). Demographic and anthropometric data of 241 patients were analyzed. The patients comprised 46.9% (n = 113) females and 53.1% (n = 128) males. It was determined that 44.4% of the individuals had transient congenital hypothyroidism and 53.6% had permanent congenital hypothyroidism. The parents of 29.8% of the individuals diagnosed with transient congenital hypothyroidism and 44.2% of the individuals diagnosed with permanent congenital hypothyroidism were consanguineous (P = .02). According to the latest anthropometric assessment, 6.8% of individuals diagnosed with congenital hypothyroidism had a weight z-score below −2 SD and 16.9% had a length z-score below −2 SD. The incidence of congenital hypothyroidism was higher in our region. The ratio of consanguinity between parents was higher in patients diagnosed with permanent congenital hypothyroidism than in those diagnosed with transient congenital hypothyroidism. According to the most recent follow-up, weight and age were found to be similar in patients with transient and permanent congenital hypothyroidism.Article Citation - WoS: 2Citation - Scopus: 3Examining the effect of COVID-19 vaccines on the menstrual cycle: A study from Turkey(LWW, 2023) Toktaş, İzzettin; Akelma, Hakan; Araç, EşrefConcerns about a possible relationship between vaccination against Coronavirus Disease 2019 (COVID-19) and menstrual disorders have been raised in the media. In addition, different studies have shown that the COVID-19 vaccine may be associated with menstrual changes. This study was conducted to investigate the effects of COVID-19 vaccines on the menstrual cycle in women. This cross-sectional descriptive study was conducted between August 16 and September 17, 2021. Data were collected through a self-administered questionnaire via an online form sent to the participants through social media. Data of 586 women were included in this study. A total of 82.4% (n = 483) of the participants were aged between 31 and 50 years. The BioNTech vaccine (2 doses) was administered to 75.8% (n = 444), Sinovac (3 doses) to 9.0% (n = 53) of the participants. 53.1% (n = 311) of the women experienced changes in their menstrual cycles. The most common menstrual changes after vaccination were delayed menstruation (n = 176; 30.0%) and prolonged menstrual duration (n = 132; 22.5%). Menstrual delay, prolonged menstrual duration, heavy bleeding, and early menstruation were more common in women than prior to receiving the vaccine (P < .05). More than half of the women experienced menstrual cycle changes after receiving the COVID-19 vaccine. Women experienced significantly higher rates of menstruation delay, prolonged menstrual duration, heavy bleeding, and early bleeding compared to before vaccination.